Cite
Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma.
MLA
Narahara, Satoshi, et al. “Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma.” Hepatology Communications, vol. 6, no. 5, May 2022, pp. 1198–212. EBSCOhost, https://doi.org/10.1002/hep4.1872.
APA
Narahara, S., Watanabe, T., Nagaoka, K., Fujimoto, N., Furuta, Y., Tanaka, K., Tokunaga, T., Kawasaki, T., Yoshimaru, Y., Setoyama, H., Oniki, K., Saruwatari, J., Tateyama, M., Naoe, H., Tanaka, M., Tanaka, Y., & Sasaki, Y. (2022). Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma. Hepatology Communications, 6(5), 1198–1212. https://doi.org/10.1002/hep4.1872
Chicago
Narahara, Satoshi, Takehisa Watanabe, Katsuya Nagaoka, Nahoko Fujimoto, Yoki Furuta, Kentaro Tanaka, Takayuki Tokunaga, et al. 2022. “Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma.” Hepatology Communications 6 (5): 1198–1212. doi:10.1002/hep4.1872.